Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,083 INR | +4.79% | +8.43% | +33.33% |
May. 28 | INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher | RE |
May. 28 | Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024 |
Sales 2024 | 39.99B 479M | Sales 2025 * | 47.62B 571M | Capitalization | 185B 2.22B |
---|---|---|---|---|---|
Net income 2024 | 13.88B 166M | Net income 2025 * | 17.34B 208M | EV / Sales 2024 | 4.26 x |
Net cash position 2024 * | 15.67B 188M | Net cash position 2025 * | 31.57B 378M | EV / Sales 2025 * | 3.23 x |
P/E ratio 2024 |
12.3
x | P/E ratio 2025 * |
10.7
x | Employees | 3,946 |
Yield 2024 * |
0.97% | Yield 2025 * |
1.16% | Free-Float | 46.76% |
Latest transcript on NATCO Pharma Limited
1 day | +4.65% | ||
1 week | +8.43% | ||
Current month | +8.43% | ||
1 month | +8.73% | ||
3 months | +6.54% | ||
6 months | +38.25% | ||
Current year | +33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 47 | 00-07-02 | |
Founder | 78 | 81-09-18 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 78 | 81-09-18 | |
Chief Executive Officer | 47 | 00-07-02 | |
Director/Board Member | 70 | 14-04-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +4.86% | - | |
0.00% | 45 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.23% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1,084 | +4.88% | 446 507 |
24-06-06 | 1,034 | +1.83% | 1,297,615 |
24-06-05 | 1,015 | +4.62% | 1,696,876 |
24-06-04 | 970.4 | -3.00% | 1,464,608 |
24-06-03 | 1,000 | +0.27% | 1,410,126 |
Delayed Quote NSE India S.E., June 07, 2024 at 12:11 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.33% | 2.18B | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- NATCOPHARM Stock